Fasting-mimicking diet to improve prostate cancer and metabolism
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy- or scan-confirmed metastatic prostate cancer that still responds to lowering testosterone (castrate sensitive)
- You are starting (or recently started) first-line stronger hormone treatment within 30 days, such as abiraterone, apalutamide, enzalutamide, or darolutamide
- You can read, write, and understand English or Spanish and can talk by phone with the study dietitian
- You have no known allergy to ingredients listed on the study’s ingredient list
- You are not underweight (BMI must be 20 or higher)
- You are not trying to lose weight, using weight-loss medications, or planning weight-loss surgery soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This study tests whether combining a time-restricted eating plan, a heart-healthy diet, and a weight-loss medication (GLP-1 receptor agonist) can help improve heart health and weight in men with prostate cancer who are receiving hormone therapy. It aims to reduce the risk of heart problems caused by hormone treatment.
This study explores how race affects nutrition for men receiving hormone therapy (ADT) for prostate cancer. It may help researchers understand if different dietary approaches are needed based on race.
This trial adds a fasting-mimicking diet to standard chemotherapy before surgery for a specific type of breast cancer. The diet may help make the chemotherapy work better while reducing side effects.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This trial tests a special low-calorie diet (fasting-mimicking diet) combined with two types of medicine (immunotherapy and targeted therapy) for people with advanced kidney cancer. The diet might help the medicines work better.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.